Catherine Sibyl Diefenbach
20PUBLICATIONS
139CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Mar 19, 2026
Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma.Grace Baek, Gaurav Varma, Samuel Yamshon
|Feb 09, 2026
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma.Catherine Diefenbach, Opeyemi Jegede, Victoria Wang
|Nov 28, 2025
A retrospectively registered pilot randomized controlled trial of postbiotic administration during antibiotic treatment increases microbiome diversity and enriches health-associated taxa.Jonas Schluter, William Jogia, Fanny Matheis
|May 01, 2025
Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results.Bruce D Cheson, Nancy L Bartlett, Betsy Knopf
|Dec 20, 2024
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies.Matthew S Davids, Danielle M Brander, Yesid Alvarado-Valero
|Jun 27, 2024
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma.Edgar Gonzalez-Kozlova, Hsin-Hui Huang, Opeyemi A Jagede
Pageof 4
Frequent Collaborators
4 joint publications
Nancy L Bartlett
3 joint publications
Izidore S Lossos
3 joint publications
Stephen D Smith
3 joint publications
Gaurav Varma
2 joint publications
Christopher R D'Angelo
2 joint publications
Catherine Zhu
2 joint publications
Chan Yoon Cheah
2 joint publications
Nadia Khan
2 joint publications
Narendranath Epperla
2 joint publications
Mark Bower
